First- versus Third-Generation EGFR Tyrosine Kinase Inhibitors in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases

SIMPLE SUMMARY: Targeted therapies have emerged as newer systemic options for certain cancers. EGFR-directed Tyrosine Kinase Inhibitors (EGFR-TKIs), which have several generations, have been found effective in a type of lung cancer called non-small cell lung cancer (NSCLC) when compared to conventio...

Descripción completa

Detalles Bibliográficos
Autores principales: Tatineni, Vineeth, O’Shea, Patrick J., Ozair, Ahmad, Khosla, Atulya A., Saxena, Shreya, Rauf, Yasmeen, Jia, Xuefei, Murphy, Erin S., Chao, Samuel T., Suh, John H., Peereboom, David M., Ahluwalia, Manmeet S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137202/
https://www.ncbi.nlm.nih.gov/pubmed/37190312
http://dx.doi.org/10.3390/cancers15082382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137202/
https://www.ncbi.nlm.nih.gov/pubmed/37190312
http://dx.doi.org/10.3390/cancers15082382

Ejemplares similares